| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2764229 | Journal of Clinical Anesthesia | 2007 | 4 Pages |
Abstract
A young, healthy adult man exhibited naloxone–reversible, prolonged apnea after a 4-hour infusion of remifentanil, which was used as the opioid component of a general endotracheal anesthetic. Clinical experience and pharmacokinetic simulations indicate that the apnea was clearly atypical.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Reed Y. Nelson, Brad Bretz, Talmage D. Egan,